Related Experiment Video
Updated: May 27, 2026
04:19
A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
Published on: May 10, 2022
Disordered eating behaviors in type 1 diabetic patients.
Alejandra Larrañaga1, María F Docet, Ricardo V García-Mayor
1Alejandra Larrañaga, Ricardo V García-Mayor, Eating Disorders Unit, University Hospital of Vigo, 36204 Vigo, Spain.
World Journal of Diabetes
|November 17, 2011
Summary
Type 1 diabetes patients face high risks of disordered eating behaviors (DEB), including diabulimia, leading to poor metabolic control and complications. Early detection and multidisciplinary care are crucial for managing these conditions.
Area of Science:
- Endocrinology
- Psychiatry
- Public Health
Background:
- Type 1 diabetes mellitus (T1DM) is a common chronic illness in youth.
- Disordered eating behaviors (DEB) and eating disorders (ED) frequently coexist with T1DM, particularly in adolescents and young adults.
- Weight management challenges in T1DM can lead to insulin restriction (diabulimia) for weight control.
Purpose of the Study:
- To highlight the significant risks and management strategies for DEB and ED in patients with T1DM.
- To emphasize the association between ED and adverse health outcomes in T1DM.
- To advocate for increased research in this vulnerable population.
Main Methods:
- Literature review and clinical observation synthesis.
- Analysis of the impact of ED on T1DM metabolic control and complication onset.
- Description of a multidisciplinary team approach for management.
Main Results:
- ED in T1DM is linked to impaired metabolic control, increased ketoacidosis, and premature microvascular complications (e.g., retinopathy).
- Effective management necessitates integrated diabetes care, nutritional support, and psychological therapy.
- A high index of suspicion is recommended for early identification, especially in young women with poor glycemic control or weight concerns.
Conclusions:
- DEB and ED pose severe medical risks for T1DM patients, necessitating prompt recognition and intervention.
- A multidisciplinary team approach is essential for comprehensive patient care.
- Further clinical and technological research is critical to improve treatment outcomes and the long-term health of at-risk individuals.
Related Concept Videos
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...